Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SDHB | P21912 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 4/20 | 0.36 |
| ▸ | RAB9A | P51151 | 4/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TNFSF10 | P50591 | 1/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.36 |
| ▸ | ALPI | P09923 | 1/20 | 0.36 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL80269 | 0.91 | NPC1 (0.41) | NPC1RAB9AHTTCYP1A2LMNA | |
| SCHEMBL22129836 | 0.91 | NPC1 (0.41) | NPC1RAB9AHTTCYP1A2LMNA | |
| SCHEMBL4147627 | 0.89 | NPC1 (0.40) | NPC1RAB9AHTTCYP1A2LMNA | |
| SCHEMBL18344442 | 0.84 | KDM4E (0.39) | NPC1RAB9AHTTCYP1A2LMNA | |
| SCHEMBL18344448 | 0.82 | LMNA (0.41) | NPC1RAB9AHTTCYP1A2LMNA | |
| SCHEMBL18344284 | 0.82 | KDM4E (0.44) | NPC1RAB9AALPLALPINR1H4 | |
| SCHEMBL8956226 | 0.81 | MAPT (0.43) | NPC1RAB9AHTTCYP1A2LMNA | |
| SCHEMBL274973 | 0.81 | GRM5 (0.41) | NPC1RAB9AHTTCYP1A2LMNA | |
| SCHEMBL8412982 | 0.81 | NPC1 (0.38) | NPC1RAB9AHTTMAPTALDH1A1 | |
| SCHEMBL125931 | 0.80 | KIF11 (0.45) | LMNAADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180180993-A1 | NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION | COVESTRO DEUTSCHLAND AG (DE) | 2018-06-28 | — | — | US | disclosed |
| EP-3320540-A1 | NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION | Covestro Deutschland AG (DE) | 2018-05-16 | — | — | EP | disclosed |
| WO-2016207161-A1 | NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION | COVESTRO DEUTSCHLAND AG (DE) | 2016-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180180993-A1 | NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION | STUB1, BAZ2A, TIPARP | SDHB 3973/4885NPC1 4827/4885RAB9A 4572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.